Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08

November 5, 2019 7:03 AM EST

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.08), versus ($0.11) reported last year.

"The last few months have been an exciting and productive period at Viking as we prepare for important near-term milestones," stated Brian Lian, Ph.D., chief executive officer of Viking... More